Today, MobileODT announced it has raised an additional $6.825 million in a Series B fundraising round led by OrbiMed Advisors - a leading healthcare venture fund. Previous investors Tristel plc. also participated in the round. MobileODT has raised over $13 million to date.
Osso VR, a startup looking to disrupt the surgical device training space with virtual reality, has raised $2 million in seed funding in a round led by Signalfire, with participation from Anorak Ventures. The company provides software that creates a virtual operating room on VR platforms like Oculus Rift/Touch or the HTC Vive.
Abreos Biosciences, a San Diego-based biotech company and a leader in the precision dosing of biological therapeutics, is pleased to announce that it has completed a new investment round. The funding came from existing investors as well as new investor TLP Investment Partners LLC and its affiliates.
Atlanta-based cybersecurity startup Patientory raised $7.2 million in three days from 1,728 individual purchasers. The money will be used to launch Patientory's electronic medical record (EMR) storage platform, the goal of which is to unite EMR chains.
Back in 2015, I ran an article about 10 innovative Israeli startups to watch, compiled from my discussions with Hillel Fuld and others who follow the Israeli startup scene. It is now 2017, and I have assembled a new list of Israeli firms to watch. (Please note that I have specifically avoided including any information-security related businesses in this list as I cover cybersecurity firms in other pieces.)
Everybody has their favourite app, gadget or new technology that can make life easier, work more productive, and the future that much more exciting, and entrepreneurs are no different. For Virgin founder and disruptive technology fan Richard Branson, it’s graphene, the world’s thinnest material, set to revolutionise life as we know it, that he’s buzzing about.
If we think of our bodies as walking, talking ecosystems, it stands to reason that microbial collections may change in response to the foods we eat and places we live. Similarly, disease-related shifts in the human environment are expected to influence our resident microbes, even if those microbes themselves don’t cause the changes.